19 May 2020 Malaysia Explain Why Drugs Rejected From Formulary, US Pharma Tell Malaysia US-based PhRMA also says a policy is needed to bridge the gap for patients from the end of a clinical trial to listing in Malaysia’s Ministry of Health Medicines Formulary.
